A Discussion About a Hematology Career in Industry With Drs. Benjamin Kim and Mark Chao
Dr. Benjamin Kim and Dr. Mark Chao discuss what it's like for a hematologist holding an industry position.
Predicting Responses to Gemtuzumab Ozogamicin
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
Dr. Robert Peter Gale and Dr. William Fibbe pay tribute to Johannes Joseph van Rood as they shed light on the life and accomplishments of this immunohematology pioneer.
Drs. Gale and Hoelzer reflect on the career and accomplishments of Professor Theodor Fliedner in experimental and clinical hematology involving hematopoietic stem cells, radiation, and its effects.
Drs. Gale, Bennett, and Hoffman discuss factors hematologists must keep in mind when diagnosing patients with therapy-related AML or MDS, in order to prevent incorrect therapy decisions.
Dr. Robert Peter Gale and Dr. Armand Keating honor the life of this renaissance hematologist.
November-December 2017Volume 14, Issue 6
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology